tiprankstipranks
Trending News
More News >
GenSight Biologics SA (DE:G49N)
FRANKFURT:G49N
Germany Market
Advertisement

GenSight Biologics SA (G49N) Income Statement

Compare
1 Followers

GenSight Biologics SA Income Statement

Last quarter (Q4 2024), GenSight Biologics SA's total revenue was €897.00K, an increase of 46.09% from the same quarter last year. In Q4, GenSight Biologics SA's net income was €-8.15M. See GenSight Biologics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 2.63M€ 1.27M€ 2.58M€ 5.28M€ 4.39M
Gross Profit
€ 2.63M€ 3.00M€ 2.58M€ 5.28M€ 4.39M
Operating Expenses
€ 18.44M€ 30.96M€ 30.42M€ 33.40M€ 29.33M
Depreciation and Amortization
€ 1.06M€ 3.03M€ 1.03M€ 928.00K€ 926.00K
EBITDA
€ -14.76M€ -21.73M€ -26.44M€ -26.83M€ -34.13M
Operating Income
€ -15.81M€ -29.70M€ -27.84M€ -28.13M€ -24.93M
Other Income/Expenses
€ 1.83M€ 3.48M€ 215.00K€ -489.00K€ -9.08M
Pretax Income
€ -13.98M€ -26.22M€ -27.62M€ -28.61M€ -34.01M
Net Income
€ -14.00M€ -26.22M€ -27.62M€ -28.62M€ -34.02M
Per Share Metrics
Basic EPS
€ -0.15€ -0.54€ -0.60€ -0.63€ -0.97
Diluted EPS
€ -0.15€ -0.54€ -0.60€ -0.63€ -0.97
Weighted Average Shares Outstanding
95.76M 48.32M 46.33M 45.15M 35.13M
Weighted Average Shares Outstanding (Diluted)
95.76M 48.32M 46.33M 45.15M 35.13M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis